Hideki Kazuno

Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2′-deoxyribonucleosides

Masakazu Fukushima, Norihiko Suzuki, Tomohiro Emura et al. · Biochemical Pharmacology · 2000 · 236 citations

Specific Inhibitors, Medicinal Chemistry, Antitumor 2′-Deoxyribonucleosides +7

Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells.

Yuko Murakami, Hideki Kazuno, Tomohiro Emura et al. · International Journal of Oncology · 2000 · 99 citations

Tumor Biology, Different Mechanisms, Oncology +13

Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: Optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase

Shingo Yano, Hideki Kazuno, Tsutomu Sato et al. · Bioorganic & Medicinal Chemistry · 2004 · 53 citations

Medicinal Chemistry, Derivative (Chemistry), Biochemistry +10

The Novel VEGF Receptor/MET–Targeted Kinase Inhibitor TAS-115 Has Marked <i>In Vivo</i> Antitumor Properties and a Favorable Tolerability Profile

Hidenori Fujita, Kazutaka Miyadera, Masanori Kato et al. · Molecular Cancer Therapeutics · 2013 · 37 citations

The first total synthesis of tetronasin (M139603)

Kozo Hori, Hideki Kazuno, Keiichi Nomura et al. · Tetrahedron Letters · 1993 · 32 citations

First Total Synthesis, Synthesis Method, Chemistry